I dati arrivano dallo studio ESSENCE (Sanyal AJ et al., NEJM 2025): a 72 settimane, il 62,9% dei pazienti in semaglutide ha ottenuto risoluzione della MASH senza peggioramento della fibrosi (vs 34,3% del placebo)
Plant-derived antioxidants can protect this part of the nervous system with immune function, thereby increasing its ability to resist damage and repair itself
While moderate ROS levels are involved in a spectrum of signaling pathways that are vital for cell growth, differentiation, and progression, elevated ROS levels are potent triggers of cell death [7]
These combined effects result in improved postprandial glucose control and reduced fasting glucose levels
Non-alcoholic fatty liver disease Non-alcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis, which is influenced by factors such as obesity, insulin resistance, dyslipidemia, and genetic predispositions, leading to lipid accumulation in the liver [64]
Oral formulationsOral Semaglutide ($289/mo), Oral Tirzepatide ($349/mo), and GLP-Squared Oral ($389/mo)provide alternatives for patients who prefer not to inject